Alessandro Vindigni, PhD

Research Interest

Aberrant DNA replication is one of the leading causes of mutations and chromosome rearrangements associated with several cancer related pathologies. At the same time, agents that stall or damage DNA replication forks are widely used for chemotherapy, in the attempt to selectively target highly proliferating cancer cells. Our group studies the mechanisms that operate in eukaryotic cells to maintain replication fork integrity upon chemical treatment with cancer chemotherapeutics.

Education

• 1995: PhD, biochemistry and molecular biophysics, University of Padua, Padua, Italy

Training

• 1995 - 1999: Postdoctural fellow, Washington University

Journal Articles

Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.